InvestSMART

Alcidion Group Limited (ASX: ALC) - Announcements

- Current share price for ALC : $0.105

ASX company news and announcements for Alcidion Group Limited (ALC) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Alcidion Group Limited (ALC) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Alcidion Group Limited (ALC), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Alcidion Group Limited (ALC)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$142 Alcidion expands partnership with NextGate to UK market 25 Nov 2020 8:23AM $0.205 $0.105 fallen by 48.78%
$142 Change of Director's Interest Notices x2 23 Nov 2020 2:31PM $0.195 $0.105 fallen by 46.15%
$142 Appendix 3G 20 Nov 2020 2:17PM $0.190 $0.105 fallen by 44.74%
$142 Constitution 19 Nov 2020 4:50PM $0.185 $0.105 fallen by 43.24%
$142 Results of Annual General Meeting 19 Nov 2020 4:44PM $0.185 $0.105 fallen by 43.24%
$142 2020 AGM Presentation 19 Nov 2020 1:36PM $0.185 $0.105 fallen by 43.24%
$142 AGM Chair Address 19 Nov 2020 1:27PM $0.185 $0.105 fallen by 43.24%
$142 Alcidion signs milestone $9.5M deal with NHS Trust 9 Nov 2020 8:22AM $0.125 $0.105 fallen by 16%
$142 Appendix 4C and Related Party Transactions Clarifications 6 Nov 2020 10:25AM $0.130 $0.105 fallen by 19.23%
$142 Q1 FY2021 Business Update and Appendix 4C 27 Oct 2020 8:34AM $0.120 $0.105 fallen by 12.50%
$142 Alcidion Quarterly Results and Investor Webcast Notification 20 Oct 2020 8:18AM $0.130 $0.105 fallen by 19.23%
$142 Notice of Annual General Meeting/Proxy Form 16 Oct 2020 4:33PM $0.125 $0.105 fallen by 16%
$142 Issue of Performance Rights under Employee Incentive Program 16 Oct 2020 10:39AM $0.130 $0.105 fallen by 19.23%
$142 Change of Director's Interest Notice 29 Sep 2020 8:25AM $0.130 $0.105 fallen by 19.23%
$142 FY2020 Results Presentation 9 Sep 2020 8:43AM $0.130 $0.105 fallen by 19.23%
$142 Appendix 4G and Corporate Governance Statement 27 Aug 2020 10:02AM $0.140 $0.105 fallen by 25%
$142 FY2020 Results Release 27 Aug 2020 9:58AM $0.140 $0.105 fallen by 25%
$142 FY20 Annual Report to shareholders 27 Aug 2020 9:50AM $0.140 $0.105 fallen by 25%
$142 Appendix 4E - Preliminary Final Report 27 Aug 2020 9:36AM $0.140 $0.105 fallen by 25%
$142 ALC FY2020 Full Year Results & Investor Webcast Notification 21 Aug 2020 8:25AM $0.135 $0.105 fallen by 22.22%
$142 Alcidion appointed to NHS Communications Framework 6 Aug 2020 8:45AM $0.135 $0.105 fallen by 22.22%
$142 Q4 FY2020 Business Update and Appendix 4C 27 Jul 2020 8:22AM $0.160 $0.105 fallen by 34.38%
$142 NHS Lanarkshire to deploy Patientrack across entire board 24 Jul 2020 8:22AM $0.150 $0.105 fallen by 30%
$142 Alcidion Quarterly Results and Investor Webcast Notification 21 Jul 2020 3:17PM $0.160 $0.105 fallen by 34.38%
$142 Alcidion signs new contract extension with ACT Health 17 Jul 2020 8:30AM $0.150 $0.105 fallen by 30%

326 - 350 of 592 results

Page 14 of 24

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.